These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26551662)

  • 1. Treatment of sulfonylurea and insulin overdose.
    Klein-Schwartz W; Stassinos GL; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):496-504. PubMed ID: 26551662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.
    Rath S; Bar-Zeev N; Anderson K; Fahy R; Roseby R
    J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide for the treatment of sulfonylurea poisoning.
    Glatstein M; Scolnik D; Bentur Y
    Clin Toxicol (Phila); 2012 Nov; 50(9):795-804. PubMed ID: 23046209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
    Boyle PJ; Justice K; Krentz AJ; Nagy RJ; Schade DS
    J Clin Endocrinol Metab; 1993 Mar; 76(3):752-6. PubMed ID: 8445035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of sulfonylurea ingestions.
    Spiller HA
    Pediatr Emerg Care; 1999 Jun; 15(3):227-30. PubMed ID: 10389964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide for the treatment of intentional insulin aspart overdose in a non-diabetic patient.
    Dewaal CM; McGillis E; Mink M; Lucyk S
    CJEM; 2018 Jul; 20(4):643-647. PubMed ID: 29202888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
    Lheureux PE; Zahir S; Penaloza A; Gris M
    Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R; Zed PJ
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of octreotide acetate to prevent rebound hypoglycaemia in sulfonylurea overdose.
    Hassan Z; Wright J
    Emerg Med J; 2007 Aug; 24(8):580-1. PubMed ID: 17652687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicenter study of sulfonylurea ingestion in children.
    Spiller HA; Villalobos D; Krenzelok EP; Anderson BD; Gorman SE; Rose SR; Fenn J; Anderson DL; Muir SJ; Rodgers GC
    J Pediatr; 1997 Jul; 131(1 Pt 1):141-6. PubMed ID: 9255206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous octreotide infusion for sulfonylurea-induced hypoglycemia in a toddler.
    Llamado R; Czaja A; Stence N; Davidson J
    J Emerg Med; 2013 Dec; 45(6):e209-13. PubMed ID: 23827165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylurea intoxication at a tertiary care paediatric hospital.
    Glatstein M; Garcia-Bournissen F; Scolnik D; Koren G
    Can J Clin Pharmacol; 2010; 17(1):e51-6. PubMed ID: 20124602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide's role in the management of sulfonylurea-induced hypoglycemia.
    Dougherty PP; Klein-Schwartz W
    J Med Toxicol; 2010 Jun; 6(2):199-206. PubMed ID: 20352540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of various doses of octreotide for sulfonylurea-induced hypoglycemia after overdose.
    Gul M; Cander B; Girisgin S; Ayan M; Kocak S; Unlu A
    Adv Ther; 2006; 23(6):878-84. PubMed ID: 17276956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of antidiabetic medications in overdose.
    Spiller HA
    Drug Saf; 1998 Nov; 19(5):411-24. PubMed ID: 9825953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide for the treatment of hypoglycemia after insulin glargine overdose.
    Groth CM; Banzon ER
    J Emerg Med; 2013 Aug; 45(2):194-8. PubMed ID: 23669130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide.
    Fleseriu M; Skugor M; Chinnappa P; Siraj ES
    Endocr Pract; 2006; 12(6):635-40. PubMed ID: 17229659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B; Boulouffe C; Vanpee D
    Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children.
    Dougherty PP; Lee SC; Lung D; Klein-Schwartz W
    Pediatr Emerg Care; 2013 Mar; 29(3):292-5. PubMed ID: 23426239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.